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Abstract
Background: Ontologies are widely used as metadata in biological and biomedical datasets. Measures of semantic
similarity utilize ontologies to determine how similar two entities annotated with classes from ontologies are, and
semantic similarity is increasingly applied in applications ranging from diagnosis of disease to investigation in gene
networks and functions of gene products.
Results: Here, we analyze a large number of semantic similarity measures and the sensitivity of similarity values to the
number of annotations of entities, difference in annotation size and to the depth or specificity of annotation classes.
We find that most similarity measures are sensitive to the number of annotations of entities, difference in annotation
size as well as to the depth of annotation classes; well-studied and richly annotated entities will usually show higher
similarity than entities with only few annotations even in the absence of any biological relation.
Conclusions: Our findings may have significant impact on the interpretation of results that rely on measures of
semantic similarity, and we demonstrate how the sensitivity to annotation size can lead to a bias when using semantic
similarity to predict protein-protein interactions.
Keywords: Semantic similarity, Ontology, Gene ontology
Background
Semantic similaritymeasures are widely used for datamin-
ing in biology and biomedicine to compare entities or
groups of entities in ontologies [1, 2], and a large number
of similarity measures has been developed [3]. The sim-
ilarity measures are based on information contained in
ontologies combined with statistical properties of a cor-
pus that is analyzed [1]. There are a variety of uses for
semantic similarity measures in bioinformatics, includ-
ing classification of chemicals [4], identifying interacting
proteins [5], finding candidate genes for a disease [6], or
diagnosing patients [7].
With the increasing use of semantic similarity measures
in biology, and the large number of measures that have
been developed, it is important to identify a method to
select an adequate similarity measure for a particular pur-
pose. In the past, several studies have been performed
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that evaluate semantic similarity measures with respect to
their performance on a particular task such as predicting
protein-protein interactions through measures of func-
tion similarity [8–10]. While such studies can provide
insights into the performance of semantic similarity mea-
sures for particular use cases, they do not serve to identify
the general properties of a similarity measure, and the
dataset to be analyzed, based on which the suitability of
a semantic similarity measure can be determined. Specif-
ically, when using semantic measures, it is often useful
to know how the annotation size of an entity affects
the resulting similarity, in particular when the corpus to
which the similarity measure is applied has a high vari-
ance in the number of annotations. For example, some
semantic similarity measures may always result in higher
similarity values when the entities that are compared have
more annotations and may therefore be more suitable
to compare entities with the same number of annota-
tions. Furthermore, the difference in annotation size can
have a significant effect on the similarity measure so
that comparing entities with the same number of anno-
tations may always lead to higher (or lower) similarity
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values than comparing entities with a different number in
annotations.
Here, we investigate features of a corpus such as the
number of annotations to an entity and the variance (or
difference) in annotation size on the similarity measures
using a large number of similarity measures implemented
in the Semantic Measures Library (SML) [11]. We find
that different semantic similarity measures respond differ-
ently to annotation size, leading to higher or lower seman-
tic similarity values with increasing number of annota-
tions. Furthermore, the difference in the number of anno-
tations affects the similarity values as well. Our results
have an impact on the interpretation of studies that use
semantic similarity measures, and we demonstrate that
some biological results may be biased due to the choice
of the similarity measure. In particular, we show that the
application of semantic similarity measures for predicting
protein-protein interactions can result in a bias, similarly
to other ‘guilt-by-association’ approaches [12], in which
the sensitivity of the similarity measure to the annotation
size confirms a bias present in protein-protein interaction
networks so that well-connected and well-annotated pro-
teins have, on average, a higher similarity by chance than
proteins that are less well studied.
Methods
Generation of test data
We perform all our experiments using the Gene Ontology
(GO) [13], downloaded on 22 December 2015 from http://
geneontology.org/page/download-ontology and Human
Phenotype Ontology (HPO) [14], download on 1 April
2016 from http://human-phenotype-ontology.github.io/
downloads.html in OBO Flatfile Format. The version of
GO we use consists of 44,048 classes (of which 1941 are
obsolete) and HPO consists of 11,785 classes (of which
112 are obsolete). We run our experiments on several dif-
ferent sets of entities annotated with different number
of GO or HPO classes and one set of entities anno-
tated with GO classes from specific depth of the graph
structure. The first set contains 5500 entities and we ran-
domly annotated 100 entities each with 1, 2, . . . , 54, 55 GO
classes. We generate our second set of entities annotated
with HPO classes in the same fashion. The third set is a
set of manually curated gene annotations from the yeast
genome database file (gene_associations.sgd.gz) down-
loaded on 26 March 2016 from http://www.yeastgenome.
org/download-data/curation. The dataset consists of 6108
genes with annotations sizes varying from 1 to 55, and
each group of the same size contains a different number of
gene products. We ignore annotations with GO evidence
code ND (No Data). The fourth set contains 1700 entities
which is composed of 17 groups. Each group have 100 ran-
domly annotated entities with GO classes from the same
depth of the ontology graph structure.
Computing semantic similarity
After the random annotations were assigned to the enti-
ties, we computed the semantic similarity between each
pair of entities using a large set of semantic similarity
measures. We include both groupwise measures and pair-
wise measures with different strategies of combining them
[1]. Groupwise similarity measures determine similarity
directly for two sets of classes. On the other hand, indirect
similarity measures first compute the pairwise similari-
ties for all pairs of nodes and then apply a strategy for
computing the overall similarity. Strategies for the latter
include computing the mean of all pairwise similarities,
computing the Best Match Average, and others [1].
Furthermore, most semantic similarity measures rely
on assigning a weight to each class in the ontology that
measures the specificity of that class. We performed our
experiments using an intrinsic information content mea-
sure (i.e., a measure that relies only on the structure
of the ontology, not on the distribution of annotations)
introduced by [15].
The semantic similarity measures we evaluated include
the complete set of measures available in the Semantic
Measures Library (SML) [11], and the full set of measures
can be found at http://www.semantic-measures-library.
org. The SML reduces an ontology to a graph structure
in which nodes represent classes and edges in the graph
represent axioms that hold between these classes [16, 17].
The similarity measures are then defined either between
nodes of this graph or between subgraphs.
The raw data and evaluation results for all similarity
measures are available as Additional file 1: Table S1. The
source code for all experiments is available on GitHub at
https://github.com/bio-ontology-research-group/pgsim.
Measuring correlation
In order to measure the sensitivity of the similarity mea-
sures to the number of annotations we calculated Spear-
man and Pearson correlation coefficients between set of
annotations sizes and the set of average similarity of one
size group to all the others. In other words, we first com-
puted the average similarities for each entity in a group
with fixed annotation size and computed the average sim-
ilarity to all entities in our corpus. For calculating the
correlation coefficients we used SciPy library [18].
Protein-protein interactions
We evaluate our results using protein-protein interac-
tion data from BioGRID [19] for yeast, downloaded on
26 March 2016 from http://downloads.yeastgenome.org/
curation/literature/interaction_data.tab. The file contains
340,350 interactions for 9868 unique genes. We filtered
these interactions using the set of 6108 genes from the
yeast genome database and our final interaction dataset
includes 224,997 interactions with 5804 unique genes.
Kulmanov and Hoehndorf Journal of Biomedical Semantics  (2017) 8:7 Page 3 of 10
Then we compute similarities between each pair of genes
using simGIC measure [1] and Resnik’s similarity mea-
sure [20] combined with Average and Best Match Average
(BMA) strategies and generate similarity matrices. Addi-
tionally, we create a dataset with random GO annotations
for the same number of genes, and the same number of
annotations for each gene. We also generate the similarity
matrices for this set using the same similarity measures.
To evaluate our results, we use the similarity values as
a prediction score, and compute the receiver operating
characteristic (ROC) curves (i.e., a plot of true positive
rate as function of false positive rate) [21] for each similar-
ity measure by treating pairs of genes that have a known
PPI as positive and all other pairs of proteins as negatives.
In order to determine if our results are valid for
protein-protein interaction data from other organisms,
we perform a similar evaluation with mouse and human
interactions. We downloaded manually curated gene
function annotations from http://www.geneontology.org/
gene-associations/ for mouse (gene_associations.mgi.gz)
and human (gene_associations.goa_human.gz) on 12
November 2016. The mouse annotations contain 19,256
genes with annotations size varying from 1 to 252 and
human annotations contain 19,256 genes with annota-
tions size varying from 1 to 213. We generate random
annotations with the same annotations sizes for both
datasets and compute similarity values using Resnik’s
similarity measure combined with BMA strategy. For
predicting protein-protein interactions we use BioGRID
interactions downloaded on 16 November 2016 from
https://thebiogrid.org/download.php. There are 38,513
gene interactions for mouse and 329,833 interactions for
human.
Gene-Disease associations
To evaluate our results with differnt ontologies, we aim
to predict gene–disease associations using phenotypic
similarity between genes and diseases. We use mouse
phenotype annotations and mouse gene–disease associ-
ations downloaded from http://www.informatics.jax.org/
downloads/reports/index.html (MGI_PhenoGenoMP.rpt
andMGI_Geno_Disease.rpt). The dataset contains 18,378
genes annotated with Mammalian Phenotype Ontology
(MPO) [22] classes with size varying from 1 to 1671, and
1424 of genes have 1770 associations with 1302Mendelian
diseases. We downloaded Mendelian disease phenotype
annotations from http://compbio.charite.de/jenkins/job/
hpo.annotations.monthly/lastStableBuild/ and generated
random annotations with the same sizes for both gene and
disease annotation datasets. We computed similarity of
each gene to each disease by computing the Resnik’s simi-
larity measure combined with BMA strategy between sets
of MPO terms and HPO terms based on PhenomeNET
Ontology [6]. Using this similarity value as a prediction
score we computed ROC curves for real and random
annotations.
Results and discussion
Our aim is to test threemain hypothesis. First, we evaluate
whether the annotation size has an effect on similar-
ity measures, and quantify that effect using measures of
correlation and statistics. We further evaluate whether
annotation size has an effect on the variance of similarity
values. Second, we evaluate whether the difference in the
number of annotations between the entities that are com-
pared has an effect on the similarity measure, and quan-
tify the effects through measures of correlation. Third,
we evaluate whether the depth of the annotation classes
has an effect on similarity measures. Finally, we classify
semantic similarity measures in different categories based
on how they behave with respect to annotation size, differ-
ences in annotation size and depth of annotation classes,
using the correlation coefficients between similarity value.
To measure the effects of annotation size, we fix the
number of annotations of entities in our test corpus, and
compare those with a certain number of annotations to all
other entities. As we have generated 100 entities for each
of the 55 annotation sizes in our corpus, we obtain a distri-
bution of 550,000 (100 × 5500) similarity values for each
annotation size. In the resulting distribution of similarity
values, we compute average (arithmetic mean) similarity
and variance. To determine if, and how much, the sim-
ilarity values increase with annotation size, we compute
Spearman and Pearson correlation coefficients for each
similarity measure. The results for a selected set of simi-
larity measures are shown in Table 1, and for Resnik’s sim-
ilarity measure [20] (with the Best Match Average strategy
for combining pairwise measures) and the simGIC mea-
sure [1] in Fig 1.We find that, in general and across almost
all similarity measures, similarity values increase with the
number of annotations associated with an entity. The vari-
ance in the average similarities, however, either increases
or decreases with the annotation size, depending on the
similarity measure.
To determine whether the results we obtain also hold for
a real biological dataset, we further evaluated the semantic
similarity between yeast proteins using a set of selected
semantic similarity measures. We find that the results in
our test corpus are also valid for the semantic similarly
of yeast proteins. Figure 1 shows the average similarity of
yeast proteins as a function of the annotation size for two
semantic similarity measures.
For example, the protein YGR237C has only a single
annotation, and the average similarly, using the simGIC
measure, is 0.035 across the set of all yeast proteins. On
the other hand, protein CDC28, a more richly annotated
protein with 55 annotations, has as average similarly 0.142
(more than 4-fold increase). These results suggest that
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Table 1 Spearman and Pearson correlation coefficients between similarity value and absolute annotation size as well as between
variance in similarity value and annotation size
Similarity measure Spearman Pearson
Yeast Synthetic GO Synthetic HPO Yeast Synthetic GO Synthetic GO




0.929780 0.251586 0.970924 –0.773449 0.953247 –0.980159 0.861348 0.117734 0.831167 –0.744321 0.802873 –0.958817
NTO (Normalized
Term Overlap)
0.178345 –0.860012 0.248990 –0.976335 0.123304 –0.988240 –0.014072 –0.682683 –0.009088 –0.574883 –0.158914 –0.593458
UI (Union
Intersection)




0.960133 –0.892027 0.998773 –0.993506 0.999351 –0.996609 0.892576 –0.812184 0.895020 –0.629497 0.907974 –0.692269
BMA with
Lin 1998
0.980519 –0.800362 0.998918 –0.994733 0.999134 –0.998052 0.925181 –0.772250 0.896497 –0.638574 0.917599 –0.677309
BMA with
Resnik 1995
0.980519 –0.717457 0.998773 –0.994228 0.998918 –0.998124 0.939044 –0.703981 0.895107 –0.642652 0.917738 –0.675426
BMA with
Schlicker 2006
0.980519 –0.800362 0.998918 –0.994733 0.999134 –0.998052 0.925181 –0.772250 0.896497 –0.638574 0.917599 –0.677309
some entities have, on average and while comparing simi-
larity to exactly the same set of entities, higher similarity,
proportional to the number of annotations they have.
As our second experiment, we evaluate whether the
difference in annotation size has an effect on the similar-
ity measure. We follow the same strategy as in our first
experiment: we have used the same datasets but measured
the average similarities as function of absolute difference
of compared entities. For the annotation sizes from 1 to
55 we get 55 groups of similarities with annotation size
difference from 0 to 54, and for each group we com-
puted average similarity and variance in similarity values.
Furthermore, we computed Pearsson and Spearman cor-
relation coefficients between annotation size difference
and average similarities to determine the sensitivity of the
similarity to annotation size difference. Figure 1 shows our
results using synthetic data as well as functional anno-
tations of yeast proteins for Resnik’s similarity measure
(using the Best Match Average strategy) and the simGIC
measure, and Table 2 summarizes the results. Full results
are available as supplementary material. We find that for
most measures, average similarity decreases as the dif-
ference in annotation size increases, while the variance
in similarity values behaves differently depending on the
similarity measure.
In our third experiment, we evaluate whether the depth
of the annotation classes has an effect on the similarity
measure. We use our fourth dataset which we randomly
generated based on the depth of classes in the GO. The
maximum depth in GO is 17, and we generate 17 groups
of random annotations. We then compute the average
similarity of the synthetic entities within one group to
all the other groups, and report Pearsson and Spearman
correlation coefficients between annotation class depth
and average similarities to determine the sensitivity of
the similarity to annotation class depth. Figure 1 shows
our results using synthetic data as well as functional
annotations of yeast proteins for Resnik’s similarity mea-
sure (using the Best Match Average strategy) and the
simGIC measure, and Table 2 summarizes the results. We
find that for most measures, average similarity increases
with the depth of the annotations, i.e., the more spe-
cific a class is the higher the average similarity to other
classes.
A classification of similarity measures
Our finding allows us to broadly group semantic similar-
ity measures into groups depending on their sensitivity to
annotation size and difference in annotation size. We dis-
tinguish positive correlation (Pearsson correlation > 0.5),
no correlation (Pearsson correlation between −0.5 and
0.5), and negative correlation (Pearsson correlation< 0.5),
and classify the semantic similarity measures based on
whether they are correlated with annotation size, dif-
ference in annotation size, and depth. Additional file 1:
Table S1 provides a comprehensive summary of our
results.
By far the largest group of similarity measures has a
positive correlation between annotation size and simi-
larity value, and a negative correlation between variance
and annotation size. Popular similarity measures such as
Resnik’s measure [20] with the Best Match Average com-
bination strategy, and the simGIC similarity measure [23],
fall in this group. A second group of similarity measures
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Fig. 1 The distribution of similarity values as a function of the annotation size (top), annotation size difference (middle) and annotation class depth
(bottom) for Resnik’s measure (using the Best Match Average strategy) and the simGIC measure
has no, or only small, correlation between annotation size
and similarity values, and might therefore be better suited
to compare entities with a large variance in annotation
sizes. The Normalized TermOverlap (NTO)measure [24]
falls into this group. Finally, a third group results in lower
similarity values with increasing annotation size.
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Table 2 Spearman and Pearson correlation coefficients between similarity value and difference in annotation size as well as between
variance in similarity value and difference in annotation size
Similarity measure Spearman Pearson
Yeast Synthetic GO Synthetic HPO Yeast Synthetic GO Synthetic GO




–0.895310 –0.931818 –0.999928 –0.999784 –0.999784 –0.997835 –0.875583 –0.503795 –0.964250 –0.484246 –0.963553 –0.496135
NTO (Normalized
Term Overlap)
0.901443 –0.233045 0.999784 0.961833 0.999784 0.959524 0.882986 –0.192168 0.990210 0.848649 0.993038 0.849263
UI (Union
Intersection)
–0.909524 –0.924459 –1.000000 –0.658658 –1.000000 –0.518687 –0.906605 –0.596963 –0.963476 –0.547645 –0.963569 –0.508495
BMA with Jiang,
Conrath 1997
0.283838 –0.925830 –0.902597 –0.521861 –0.891486 –0.770130 0.074788 –0.850654 –0.834208 –0.495874 –0.848264 –0.735985
BMA with
Lin 1998
0.462843 –0.674892 –0.901587 –0.552237 –0.891126 –0.731530 0.303157 –0.707318 –0.836486 –0.517670 –0.852998 –0.693744
BMA with
Resnik 1995
0.578211 –0.579149 –0.901587 –0.537807 –0.891126 –0.699856 0.442458 –0.487544 –0.835991 –0.507179 –0.854007 –0.670199
BMA with
Schlicker 2006
0.462843 –0.674892 –0.901587 –0.552237 –0.891126 –0.731530 0.303157 –0.707318 -0.836486 –0.517670 –0.852998 –0.693744
Impact on data analysis
In order to test our results on an established biological
use case involving computation of semantic similarity, we
conducted an experiment by predicting protein-protein
interactions using the similarity measures. Prediction of
protein-protein interactions is often used to evaluate
and test semantic similarity measures [8–10], but simi-
lar methods and underlying hypotheses are also used for
candidate gene prioritization [25] in guilt-by-association
approaches [12].
We use our manually curated set of yeast gene anno-
tations and then generated random GO annotations for
each protein in this set while maintaining the annotation
size fixed. Specifically, to generate a completely random
annotation dataset, we replace each GO annotation of
each protein in our yeast dataset by a random GO class.
Thereby, the number of annotations for each protein
remains constant, while the content of the annotation is
replaced by a random GO class. We then compute pair-
wise semantic similarity between the proteins, once using
the real annotations and additionally using the randomly
generated annotations, and we use the resulting ranking
as prediction of a protein-protein interaction. Using real
protein-protein interactions from the BioGRID database
[19], we compute the true positive rate and false positive
rate of the predictions for each rank and plot the receiver
operating characteristic (ROC) curves for both cases. The
ROC curves are shown in Fig. 2 for simGIC and Resnik
similarity measure. For example, for predicting PPIs using
Resnik’s similarity measure and the BMA strategy, the
area under the ROC curve (ROC AUC) using real biolog-
ical annotations is 0.69, while the ROC AUC for random
annotations is 0.65. Despite the complete randomization
of the annotations, ROC AUC is significantly (p ≤ 10−6,
one-sided Wilcoxon signed rank test) better than ran-
dom. We repeat this experiment with human and mouse
PPIs and Resnik’s similarity measure (Fig. 3, and find that
in each case, random annotations provide a predictive
signal. For mouse PPIs, ROC AUC with random annota-
tions is 0.63 while real GO annotations result in a ROC
AUC of 0.74, and for human PPIs, ROC AUC with ran-
dom annotations is 0.54 and 0.58 with real annotations.
In both cases, the ROC curves are significantly better
than random (p ≤ 10−6, one-sided Wilcoxon signed rank
test).
We further test if this phenomenon also holds for other
applications of semantic similarity, in particular disease
gene prioritization through phenotype similarity. For this
purpose, we use the PhenomeNET systems [6, 26] and
compare the semantic similarity associated with loss of
function mouse models and human disease phenotypes.
Using real annotations, ROC AUC is 0.90, while the ROC
AUC for random phenotype annotations is 0.73 (Fig. 4),
demonstrating that the phenomenon also holds for other
use cases besides predicting PPIs.
The good performance in predicting PPIs in the absence
of biological information is rather surprising. We hypoth-
esized that well-studied proteins generally have more
known functions and more known interactions, and also
that genes involved in several diseases have more phe-
notype annotations. The Pearson correlation coefficient
between the number of interactions and the number of
functions in our yeast dataset is 0.34, in the human dataset
0.23, and 0.36 in the mouse PPI dataset. Similarly, in our
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Fig. 2 ROC Curves for protein-protein interaction prediction using random annotations and interaction data from BioGRID for yeast
dataset of gene–disease associations, there is a correla-
tion between the number of phenotype annotations and
the number of gene–disease associations (0.42 Pearson
correlation coefficient). While the correlations are rela-
tively small, there is nevertheless a bias that is confirmed
by selecting a similarity measure that follows the same
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Fig. 3 ROC Curves for protein-protein interaction prediction using random annotations and interaction data from BioGRID for mouse and human
Fig. 4 ROC Curves for gene-disease association prediction using PhenomeNet Ontology with mouse phenotype from MGI and OMIM disease
phenotype annotations compared with random annotations
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bias. We tested whether the same phenomenon occurs
with another similarity measure that is not sensitive to
the annotation size or difference in annotation size. Using
Resnik’s measure with the Average strategy for combin-
ing the similarity values, we obtain a ROC AUC of 0.52
when predicting yeast PPIs. Although this ROC AUC is
still significantly better than random (p ≤ 10−6, one-
sidedWilcoxon signed rank test), the effect is much lower
compared to other measures.
In the context of gene networks, prior research has
shown that the amount of functional annotation and net-
work connectivity may result in biased results for certain
types of analyses, leading the authors to conclude that
the “guilt by association” principle holds only in excep-
tional cases [12]. Our analysis suggests that similar biases
may be introduced in applications of semantic similarity
measures such that heavily annotated entities will have,
on average and without the presence of any biological
relation between entities, a higher similarity to other enti-
ties than entities with only few annotations. A similar
but inverse effect exists for differences in annotation size.
Consequently, comparing entities with many annotations
(e.g., well-studied gene products or diseases) to entities
with few annotations (e.g., novel or not well-studied gene
products) will result, on average, in the lowest similar-
ity values, while comparing well-studied entities to other
well-studied entities (both with high annotation size and
no or only small differences in annotation size) will result
in higher average similarity for most similarity measures
even in the absence of any biological relation.
Conclusions
We find that the annotation size of entities clearly plays
a role when comparing entities through measures of
semantic similarity, and additionally that the difference in
annotation size also plays a role. This has an impact on
the interpretation of semantic similarity values in several
applications that use semantic similarity as a proxy for
biological similarity, and the applications include priori-
tizing candidate genes [6], validating text mining results
[27], or identifying interacting proteins [10]. Similarly to
a previous study on protein-protein interaction networks
[12], we demonstrate that the sensitivity of similarity mea-
sures to annotation size can lead to a bias when predict-
ing protein-protein interactions. These results should be
taken into account when interpreting semantic similarity
values.
In the future, methods need to be identified to correct
for the effects of annotation size and difference in annota-
tion size. Adding richer axioms to ontologies or employing
similarity measures that can utilize axioms such as dis-
jointness between classes [28] does not on its own suffice
to remove the bias we identify, mainly because the rela-
tion between annotated entities (genes or gene products)
and the classes in the ontologies does not consider dis-
jointness axioms. It is very common for a gene product to
be annotated to two disjoint GO classes, because one gene
product may be involved in multiple functions (such as
“vocalization behavior” and “transcription factor activity”)
since gene products are not instances of GO classes but
rather are related by a has function relation (or similar) to
some instance of the GO class. A possible approach could
be to rely on the exact distribution of similarity values for
individual entities [29] and use a statistical tests to deter-
mine the significance of an observed similarity value. An
alternative strategy could rely on expected similarity val-
ues based on the distribution of annotations in the corpus
and the structure of the ontology and adjusting similar-
ity values accordingly so that only increase over expected
similarity values are taken into consideration.
Additional file
Additional file 1: Supplementary Table. (PDF 17 kb)
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